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Psoriasis is a noncontagious, arytematous-squamose dermatitits affecting both 
sexes and all races. Although its exact etiology is largely unknown, it is now recog-
nized as one of the most common immune-mediated disorders and several studies 
demonstrate an impairment of regulatory T-cells (Tregs) function and an up-regula-
tion of IL-17 levels produced by T-helper 17 lymphocytes (Th17)(1,2). Protein kinase 
C epsilon (PKCε) is a serine/threonine kinase which plays a key role in the prolif-
eration and differentiation of epidermal cells. We have previously demonstrated a 
role for PKCε in the pathogenesis of the autoimmune disease Hashimoto’s thyroidi-
tis (3). PKCε is over-expressed in CD4+ T lymphocytes isolated from PBMC fraction 
in patients affected by this pathology and its forced down-modulation primed the 
TGF-mediated in vitro Treg polarization of human T CD4+ cells. Since it has been 
demonstrated that PKC-signalling is altered in psoriatic keratinocytes (4), we inves-
tigated the involvement of PKCε in Th17 in vitro differentiation and its potentially 
implication in immune response correlated to psoriasis. Using western blot and real 
time PCR, we have observed that PKCε protein levels and mRNA increase during 
Th17-lineage in vitro differentiation from naïve CD4+ T cells with a similar trend 
of Th17 markers of differentiation STAT3 and RoRyT. Moreover, PKCε overexpres-
sion significantly increases STAT3 and phosphorylated STAT3 levels, suggesting that 
PKCε boosts Th17 polarization. Thereafter, we sought to investigate PKCε expression 
in CD4+ lymphocytes obtained from peripheral blood of psoriatic patients and we 
observed that PKCε expression levels are significantly higher compared with healthy 
donors. Intriguingly, we observed a closely correlation of PKCε expression with PASI 
index, suggesting an involvement of the kinase with the severity of the disease. Col-
lectively these data suggest that PKCε might be involved in Th17 differentiation, 
that it could be a key factor to regulate Th17 pathological expansion and therefore a 
potential psoriatic pharmacological target. 
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